This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Thermo Fisher (TMO) Gets a Buy from Barclays

Tipranks - Tipranks - Tue Jun 9, 3:56AM CDT

Barclays analyst Luke Sergott maintained a Buy rating on Thermo Fisher today and set a price target of $625.00.

Introducing TipRanks MCP for Agents

Sergott covers the Healthcare sector, focusing on stocks such as Thermo Fisher, Certara, and Guardant Health. According to TipRanks, Sergott has an average return of 0.2% and a 39.86% success rate on recommended stocks.

In addition to Barclays, Thermo Fisher also received a Buy from Bank of America Securities’s Michael Ryskin in a report issued on June 2. However, on June 3, HSBC downgraded Thermo Fisher (NYSE: TMO) to a Hold.

See today’s best-performing stocks on TipRanks >>

Based on Thermo Fisher’s latest earnings release for the quarter ending March 28, the company reported a quarterly revenue of $11.01 billion and a net profit of $1.65 billion. In comparison, last year the company earned a revenue of $10.36 billion and had a net profit of $1.51 billion

Read More on TMO:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).